Medications

FDA approves Litfulo for teens, adults with alopecia areata

The U.S. Food and Drug Administration has approved Litfulo (ritlecitinib) for adults and adolescents aged 12 years and older with severe alopecia areata at a recommended dose of 50 mg. Approval of Litfulo was granted to Pfizer.

Psychology & Psychiatry

Our sense of smell alters the colors we see, show scientists

Our five senses bombard us with environmental input 24/7. One way our brain makes sense of this abundance of information is by combining information from two or more senses, such as between smells and the smoothness of textures, ...

page 7 from 40